الرئيسية › دليل الباحثين › Faten Kallel

Faten Kallel

الانتماء : University of Sfax

• 45منشورات (انتماء تونسي)
• 58مجموع المنشورات
• 54الاستشهادات
• 4مؤشر h

OpenAlex

الملف البحثي

لدى Faten Kallel 45 منشور(ات) مفهرسة (2011–2026). تُنشر أعماله أساسًا في «HemaSphere»، «Journal of Oncology Pharmacy Practice» و«Gene Reports». أكثر مقالاته استشهادًا هو «Characterization of novel mutations in the TEL-patch domain of the telomeric factor TPP1 associated with telomere biology disorders» (2024)، وقد استُشهد به 13 مرة. 5 من هذه المنشورات تعود إلى آخر ثلاث سنوات من النشاط. شارك في تأليف أعماله 12 باحثًا على الأقل.

هل هذا أنت؟ عرّف بأبحاثك

أنشئ ملفك على DzCademia مجانًا وأضف مقالاتك: ستظهر بسهولة أكبر على Google وفي مساعدي الذكاء الاصطناعي مثل ChatGPT، فيقرؤها ويستشهد بها عدد أكبر من الناس.

إنشاء ملفي المجاني إضافة منشوراتي

مجالات البحث

• Lymphoma Diagnosis and Treatment
• Acute Lymphoblastic Leukemia research
• Acute Myeloid Leukemia Research
• Retinoids in leukemia and cellular processes
• Multiple Myeloma Research and Treatments

المنشورات (45)

• MPIG6B gene mutation in a Tunisian female with myelofibrosis
  2026 · Gene Reports
• Évaluation et impact de l’incertitude chez les patients atteints de BPCO au service de pneumologie de Sfax
  2025 · Revue des Maladies Respiratoires Actualités
• Atypical acquired hemophilia linked with primary biliary cholangitis: a unique case presentation
  2025 · Future Science OA
• Primary Cutaneous NK /T‐Cell Lymphoma With Aberrant CD20 Expression Responsive to SMILE Chemotherapy
  2025 · Journal of Cutaneous Pathology
• Characterization of novel mutations in the TEL-patch domain of the telomeric factor TPP1 associated with telomere biology disorders
  2024 · Human Molecular Genetics · استُشهد به 13 مرة
• Patient Care Strategies for alloant-ibodies in Type 3 Von Willebrand Disease: A Southern Tunisia Perspective
  2023 · Journal of Taibah University Medical Sciences · استُشهد به 1 مرة
• Complexity of diagnosing and treating langerhans cell sarcoma: A case report.
  2023 · PubMed Central · استُشهد به 1 مرة
• Biclonal Gammopathies in South Tunisia: Clinical and Biological Characteristics
  2023 · Laboratory Medicine · استُشهد به 1 مرة
• Langerhans Cell Histiocytosis: an unusual cause of Diabetes Insipidus
  2023
• PB2369: PERIPHERAL T CELL LYMPHOMA: EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS
  2023 · HemaSphere
• PB2367: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH NODAL PERIPHERAL T-CELL LYMPHOMA
  2023 · HemaSphere
• PB1732: CLINICAL CHARACTERISTICS AND THERAPEUTIC RESULTS OF CHILDHOOD AND YOUNG ADULTS T - ACUTE LYMPHOBLASTIC LEUKEMIA IN SOUTH OF TUNISIA
  2023 · HemaSphere
• PB1895: CHARACTERISTICS AND OUTCOME OF PEADIATRIC ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
  2023 · HemaSphere
• PB1749: COMPARATIVE STUDY OF B AND T-ALL IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS: CLINICAL CHARACTERISTICS AND THERAPEUTIC RESULTS
  2023 · HemaSphere
• P398: HIGH-RISK CHILDHOOD AND ADOLESCENT AND YOUNG ADULTS ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH THE EORTC 58951 PROTOCOL: RESULTS AND OUTCOME
  2023 · HemaSphere
• PB2020: OUTCOMES OF PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROMES
  2023 · HemaSphere
• PB1907: EPIDEMIOLOGICAL PROFILE AND DIAGNOSTIC FEATURES OF ACUTE MYELOBLASTIC LEUKEMIA IN ADULTS: EXPERIENCE OF THE HEMATOLOGY DEPARTMENT OF SFAX
  2023 · HemaSphere
• PB1891: EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
  2023 · HemaSphere
• PB1876: SIXTEEN YEARS OF EXPERIENCE WITH THE MRC-10 PROTOCOL FOR THE TREATMENT OF ADULT ACUTE MYELOID LEUKEMIA IN THE SOUTH OF TUNISIA
  2023 · HemaSphere
• PB2650: ALLOANTIBODIES IN VON WILLEBRAND DISEASE: ABOUT 6 CASES IN SOUTHERN TUNISIA
  2023 · HemaSphere
• Pain management in patients with multiple myeloma
  2023 · Douleurs Évaluation - Diagnostic - Traitement
• Non-Hodgkin's lymphoma developed during imatinib mesylate treatment of chronic myeloid leukemia
  2022 · Journal of Oncology Pharmacy Practice · استُشهد به 3 مرة
• Hemophilia in the south of Tunisia
  2022 · Blood Coagulation & Fibrinolysis · استُشهد به 2 مرة
• PB1767: OUTCOME OF RELAPSED CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN THE SOUTH OF TUNISIA SINGLE CENTER EXPERIENCE
  2022 · HemaSphere · استُشهد به 1 مرة
• PB2095: RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: EXPERIENCE OF A LOW-INCOME CENTER IN TIME OF NEW DRUGS
  2022 · HemaSphere
• PB2017: YOUNG PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AND RENAL IMPAIRMENT: A TUNISIAN SINGLE-CENTER EXPERIENCE
  2022 · HemaSphere
• PB2093: DIFFUSE LARGE B CELL LYMPHOMA IN THE ELDERLY
  2022 · HemaSphere
• PB1989: LIGHT CHAIN AMYLOIDOSIS (AL): THE EXPERIENCE OF A TUNISIAN CENTER
  2022 · HemaSphere
• PB1819: CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
  2022 · HemaSphere
• PB1843: ACUTE MYELOID LEUKEMIA WITH PHILADELPHIA CHROMOSOME: EXPERIENCE OF SFAX HEMATOLOGY DEPARTMENT
  2022 · HemaSphere
• PB2063: CHARACTERISTICS AND THERAPEUTIC RESULTS OF PATIENTS WITH REFRACTORY/RELAPSED HODGKIN LYMPHOMA IN A TUNISIAN CENTER
  2022 · HemaSphere
• PB1990: MULTIPLE MYELOMA IN THE ELDERLY: A MONOCENTRIC EXPERIENCE
  2022 · HemaSphere
• PB1759: TWENTY-ONE YEARS’ EXPERIENCE OF ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC PROTOCOL: MONOCENTRIC STUDY
  2022 · HemaSphere
• Thymic plasmacytoma presenting as polyneuropathy and revealing multiple myeloma: a case report
  2022 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
• Aplastic anemia secondary to tyrosine kinase inhibitor therapy in a patient with chronic myeloid leukemia
  2021 · Journal of Oncology Pharmacy Practice · استُشهد به 6 مرة
• Prospective observational study of palliative care in hematological malignancies: Report of one year of practice
  2021 · Transfusion Clinique et Biologique · استُشهد به 1 مرة
• Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia
  2020 · Journal of Oncology Pharmacy Practice · استُشهد به 6 مرة
• Homozygous pArg610del Mutation Unusually Associated With Severe Delay of Growth in 2 Acid Sphingomyelinase Deficiency–affected Sibs
  2019 · Journal of Pediatric Hematology/Oncology · استُشهد به 3 مرة
• PF352 TUNISIAN FANCONI ANEMIA REGISTRY (TFAR) REPORT, THE 2018 UPDATE
  2019 · HemaSphere
• PF193 NO BLASTS AT DAY 8 IS BETTER THAN MORE IN CORTICO‐SENSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OF CHILDREN
  2019 · HemaSphere
• OUTCOME OF CHILDREN AND ADOLESCENTS WITH LYMPHOBLASTIC LYMPHOMA TREATED WITH THE EORTC 58951 PROTOCOL
  2019 · Hematological Oncology
• Depth of Response to ≥VGPR at Completion of Induction Influences Outcome Post ASCT, on Behalf of the Tunisian Myeloma Study Group
  2016 · Blood · استُشهد به 1 مرة
• Adult gaucher disease in southern Tunisia: report of three cases
  2012 · Diagnostic Pathology · استُشهد به 8 مرة
• Delivery of two normal twins exposed to imatinib and nilotinib during the first trimester of pregnancy in a woman with chronic myeloid leukemia
  2012 · Journal of Hematological Malignancies · استُشهد به 4 مرة
• Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion
  2011 · Leukemia Research · استُشهد به 1 مرة

مجلات النشر

• HemaSphere × 23
• Journal of Oncology Pharmacy Practice × 3
• Gene Reports × 1
• Revue des Maladies Respiratoires Actualités × 1
• Future Science OA × 1
• Journal of Cutaneous Pathology × 1

المنشورات حسب السنة

• 20261
• 20253
• 20241
• 202316
• 202213
• 20212
• 20201
• 20194
• 20161
• 20122

التعاون العلمي

المؤسسات الشريكة : Hopital Universitaire Hedi Chaker · Hopital Universitaire Habib Bourguiba · Faculty of Medicine of Sfax · Institut Pasteur de Tunis · Hôpital Farhat Hached

المؤلفون المشاركون

• Moez Elloumi
• Olfa Kassar
• Imen Frikha
• Imen Ben Amor
• Maha Charfi
• Moez Medhaffar
• Rahma Mallek
• Latifa Khelifa
• Moez Medhaffer
• Sondes Hdiji
• M. Elloumi
• Nour Siala

البيانات البيبليوغرافية مصدرها OpenAlex (قاعدة مفتوحة).